
Study Results Abstracts From Kelun-Biotech's TROP2 ADC Sacituzumab Tirumotecan (sac-TMT) At 2025 ASCO Genitourinary Cancers Symposium
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Hotel
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Thailand Board of Investment (BOI)